Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.

Learn the hidden signs of sleep apnea, its impact on health, and how effective treatment can restore your energy and improve overall well-being.

It could be a game-changer for the millions of Americans who suffer from sleep apnea. A new first-of-its-kind pill could ...

The Food and Drug Administration has approved Zepbound, a GLP-1 weight-loss drug from Eli Lilly & Co., for the treatment of moderate to severe sleep apnea certain patients with obesity. Photo courtesy ...

KBIA’s Rebecca Smith recently sat down with Dr. Mohammad Badran at the University of Missouri who studies sleep apnea to ...

Early management of obstructive sleep apnea in patients with IPF could slow disease progression and improve outcomes.

LIVERPOOL, N.Y. (WSYR-TV) — Sleep apnea isn’t just something that affects older adults anymore. Experts say they’re seeing ...

Please provide your email address to receive an email when new articles are posted on . Individuals with moderate to severe obstructive sleep apnea had increased odds of having neovascular AMD.

Sleep apnea often goes untreated because it doesn’t look the way most people expect it to. Many imagine loud, disruptive ...

DONGGUAN, GUANGDONG, CHINA, January 15, 2026 /EINPresswire.com/ -- As sleep disorders such as obstructive sleep apnea ...

Zepbound (tirzepatide) is a brand-name injection prescribed for treating sleep apnea. This article covers topics such as side effects, dosage, and how Zepbound works. Zepbound is available in ...